Livracin Injection (L-Aspartic Acid-L-Ornithine)

Adult administration

For hepatic encephalopathy (including pre-comatose and comatose states), L-Aspartic Acid-L-Ornithine can be mixed into an appropriate infusion solution to be administered as an intravenous drip at a maximum dosage of 40 g (8 ampoules) per day. Adjust according to symptoms as appropriate.

This medication is in the form of a glass ampoule injection, so great care must be taken to avoid glass fragments when using it. Special caution is required when using it on children or the elderly. This medication should not be administered to patients with certain conditions. For example, patients with lactic acidosis, methanol poisoning, fructose-sorbitol intolerance, specific enzyme deficiencies, and severe renal dysfunction should avoid use. Additionally, this medication contains sulfite components, which may cause allergic reactions. Caution is especially needed for asthma patients as they may have heightened sensitivity to sulfites. When using this medication, you may occasionally feel warmth at the back of the head or experience nausea, and gastrointestinal discomfort or vomiting may occur. If a high dose is administered, blood or urine urea levels should be monitored to assess the body condition. Patients with poor liver function should adjust the infusion speed to reduce discomfort. This medication should be administered slowly by intravenous injection, and care should be taken to avoid rapid infusion. Finally, it should be stored out of the reach of children, and the medication should not be transferred to another container from its original package. This helps maintain the quality of the medication and prevents accidents.

Serious side effects

Asthma attacks, severe allergic reactions like sulfite anaphylaxis

Mild side effects

• Warmth at the nape of the neck
• nausea
• gastrointestinal discomfort
• vomiting

This medication is sensitive to light and should be stored in a container that does not allow light. Furthermore, it is important to keep it at room temperature between 1°C and 30°C to maintain its effectiveness.

Appearance

A brown ampoule injection containing a clear liquid that is colorless to light yellow.

Package unit

For domestic use - 10 milliliters/ampoule [X 30], for export - 10 milliliters/ampoule [X 10]